CClinicalTrials.gg
Sign In
TerminatedNCT02704312PROCUBITUSUpdated Mar 8, 2022

Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer

An interventional study of Radiotherapy by Prone and decubitus in Breast Cancer, sponsored by University Hospital Center of Martinique. Terminated at 1 site in Martinique. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-08.

Sponsored by University Hospital Center of Martinique · Not applicable, Interventional, and Other

Why this study was terminated
Start of the Principal Investigatoir

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2015, registered Mar 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Compare dosimeters in both positions (prone and decubitus) for each patient

Read the detailed description

Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose).

02

Conditions studied

  • Breast Cancer

Browse trials for

03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 11 is below the median of 72 across 9,302 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University Hospital Center of Martinique is the lead sponsor of 77 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with primary breast cancer and in whom conservative post- surgery radiation therapy for breast cancer is prescribed.
  • Patients aged over 18 years
  • Patients with indication for conservative surgery.
  • Resection should be in healthy margin.
  • Women of childbearing potential must satisfy a negative pregnancy test at the screening visit and use effective contraception as determined by the physician of the patient throughout the study.

Exclusion criteria

Exclusion Criteria:

  • Minor Patient
  • Patients whose tumor resection is incomplete
  • Patients with an indication of mastectomy
  • Patients with a history of radiation therapy of the chest
  • Pregnant women, lactating, or of childbearing age without effective contraception.
  • Patients who had more than 4 scanners in one year. ( Scanner cervical , thoracic, or abdominal
  • Patients with an incompatible condition with monitoring protocol (psychiatric disorder, uncontrolled disease).
  • Patient unable to respond to a questionnaire
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Radiotherapy techniques

    Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose)

    Radiation: Radiotherapy by Prone and decubitus

Interventions

  • RadiationRadiotherapy by Prone and decubitus

    Dosimetric comparison of doses in target volumes and organs at risk

06

What researchers measure

Primary outcomes

  1. Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk

    Time frame: From baseline to 5 weeks

Secondary outcomes

  1. Quality of Life Questionnaire

    Time frame: Baseline and Follow up month 3, 12, 24 and 36

07

Study locations

1 site
  • CHU de Martinique
    Fort de France, Martinique
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02704312
Lead sponsor
University Hospital Center of Martinique
Responsible party
Sponsor
First posted
Mar 10, 2016
Start date
Nov 30, 2015
Primary completion
Aug 2021
Completion
Feb 11, 2022
Last update
Mar 8, 2022

Study contacts

Vincent VINH HUNG, MD
principal investigator · CHU de Martinique

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Breast Neoplasms→

Other studies from this sponsor

University Hospital Center of Martinique

Start the discussion